Navigation Links
Pharmathene in Medical News

PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

...e Warrants to purchase up to 2.6 million shares of pharmathene common stock at $2.50 per share, the closing price...able exemption from the registration requirements. pharmathene has agreed to file a registration statement under ...any securities. About PharmAthene, Inc. pharmathene was formed to meet the critical needs of the Unite...

PharmAthene Reports Year End 2008 Financial Results

...an Services issued a formal solicitation, to which pharmathene responded, requesting advanced development and pro... Conference Call and Webcast Information pharmathene management will host a conference call to discuss ...n of the website. About PharmAthene, Inc. pharmathene was formed to meet the critical needs of the Unite...

RNA engineering to combat series of illnesses wins Kaye Award for Hebrew University dean

...folio. As an example of one way in which this manipulation can deal with protein excess or deficiency, Prof. Soreq cites the work being done by the pharmathene Company in Annapolis, Maryland. This company, under license from Yissum, has developed a herd of goats which had been engineered to produce the human ...

Iomai Wins Department of Defense Grant to Develop a Stable, Patch-Based Anthrax Vaccine

...cal countermeasures against biological and chemical threats, announced that they had entered into a definitive sale and purchase agreement under which pharmathene will acquire all of the assets and intellectual property related to Avecia's biodefense vaccines business. Some matters discussed in this press rele...

PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM)

...propriations bill includes $0.8 million payable to pharmathene on a cost reimbursement basis to support ongoing d...ered strains of anthrax. About PharmAthene, Inc. pharmathene (Amex: PIP ) was formed to meet the critical need...similar statements are forward-looking statements. pharmathene disclaims, however, any intent or obligation to up...

PharmAthene to Present at the Rodman and Renshaw/Acumen BioFin 9th Annual Healthcare Conference

...site at http://www.pharmathene.com under the Investor Relations section, or at http://www.wsw.com/webcast/rrshq12/pip . About PharmAthene, Inc. pharmathene (AMEX: PIP ) was formed to meet the critical needs of the United States and its Allies by developing and commercializing medical countermeasures agai...
Pharmathene in Medical Technology

PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)

...al, biological, radiological and nuclear threats. pharmathene has requested funding to further develop Valortim(... requirement for the Strategic National Stockpile. pharmathene believes that Valortim(R) is well positioned for p...rains of anthrax. About PharmAthene, Inc. pharmathene was formed to meet the critical needs of the Unite...

PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA

...an biomedical stockpile. In September 2008, pharmathene received notification from HHS that its proposal f...e for procurement consideration. Since that time, pharmathene has been engaged in negotiations with HHS under th...hrax Ames strain. About PharmAthene, Inc. pharmathene was formed to meet the critical needs of the Unite...

PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program

...ite at www.pharmathene.com . A link to the webcast may be found on the Investor Relations section of the website. About PharmAthene, Inc. pharmathene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological...

Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology

...e included in the Strategic National Stockpile and pharmathene believes that Valortim(R) is well positioned to ad...rains of anthrax. About PharmAthene, Inc. pharmathene was formed to meet the critical needs of the Unite...imilar statements are forward-looking statements. pharmathene disclaims, however, any intent or obligation to up...

PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R)

...udy for Protexia(R) is a significant milestone for pharmathene as it represents continued progress in the develop...ilian stockpile requirements." In September 2006 pharmathene was awarded a multi-year contract valued at up to ...ed development of Protexia(R). Under the contract, pharmathene is responsible for the conduct and oversight of al...

PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop

... in the biodefense sector. As the data illustrate, pharmathene continues to advance its pipeline and further its ...death in severe cases. About PharmAthene, Inc. pharmathene was formed to meet the critical needs of the Unite...similar statements are forward-looking statements. pharmathene disclaims, however, any intent or obligation to up...

PharmAthene's Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimer's Disease

...e results continue to be encouraging, it may allow pharmathene to expand applications of rBChE to additional area... part of the collaboration with Hebrew University, pharmathene has an exclusive, worldwide license to the applica...are exceedingly toxic. About PharmAthene, Inc. pharmathene (Amex: PIP ) was formed to meet the critical need...

PharmAthene to Webcast its Third Quarter Conference Call on November 13, 2007 at 4:30 P.M. Eastern Time

... ANNAPOLIS, Md., Nov. 6 /PRNewswire-FirstCall/ -- pharmathene (Amex: PIP), a biodefense company specializing in the development of medica... webcast for 30 days, or until December 13, 2007. About PharmAthene, Inc. pharmathene is a biodefense company formed in 2001 to meet the critical needs of the Un...

Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic Effect in New Primate Model of Established Anthrax Infection

.... PharmAthene, a privately-held biotechnology company, was formed to meet the critical needs of the United States by developing biodefense products. pharmathene is dedicated to the rapid development of important and novel biotherapeutics to address biological pathogens and chemicals that may be used as weapons...

Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic Effect in New Primate Model of Established Anthrax Infection

.... PharmAthene, a privately-held biotechnology company, was formed to meet the critical needs of the United States by developing biodefense products. pharmathene is dedicated to the rapid development of important and novel biotherapeutics to address biological pathogens and chemicals that may be used as weapons...
Pharmathene in Biological News

Promising new treatment for Alzheimer's suggested based on Hebrew University research

...s, as well as engineered human BChE produced in the milk of transgenic goats at a U.S. company, Pharmathene. The goat- produced protein is prepared at pharmathene for the U.S. military as protection from nerve gas poisoning (a result of earlier research at the Hebrew University). It was much more stable and effi...
Pharmathene in Biological Technology

Medarex And PharmAthene Announce New Therapeutic Data for Anthrax Anti-Toxin, Valortim(R)

- Data Presentation at 48th ICAAC / IDSA 46th Annual Meeting - PRINCETON, N.J. and ANNAPOLIS, Md., Oct. 28 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ), a leading monoclonal antibody company, and PharmAthene, Inc. (NYSE: PIP ), a biodefense company developing medical counterm...

Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court

ANNAPOLIS, Md., Aug. 13 /PRNewswire-FirstCall/ -- PharmAthene, Inc., (Amex: PIP ) a biodefense company developing and commercializing medical countermeasures against biological and chemical threats, announced today that proceedings have been initiated with the Delaware Chancery Court to affir...

Lord Lewis Moonie to Serve as Special UK Government Advisor to PharmAthene

Pursing International Market Opportunities for the Company's Medical Countermeasures ANNAPOLIS, Md., Aug. 11 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, ...

PharmAthene to Host Second Quarter 2009 Conference Call and Webcast on Thursday, August 13, 2009

...econd quarter of 2009 will be released on Thursday, August 13, 2009. pharmathene management will be hosting a conference call to discuss its second quarter ...until approximately September 12, 2009. About PharmAthene, Inc. pharmathene was formed to meet the critical needs of the United States and its allies b...

PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

...d Warrants to purchase up to 2.6 million shares of pharmathene common stock at $2.50 per share, the closing price...able exemption from the registration requirements. pharmathene has agreed to file a registration statement under ...any securities. About PharmAthene, Inc. pharmathene was formed to meet the critical needs of the Unite...

PharmAthene's 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review

...Stockpile, as previously announced on May 22, 2009 pharmathene submitted to FDA its development strategy, includi...ng the regulatory strategy for their rPA vaccine. pharmathene has provided FDA's feedback to the Biomedical Adva...tes of Health. About PharmAthene, Inc. pharmathene was formed to meet the critical needs of the Unite...

PharmAthene Reports First Quarter 2009 Financial and Operational Results

...arch 31, 2009. For the first quarter of 2009, pharmathene recognized revenues of $5.5 million compared to $5... Conference Call and Webcast Information pharmathene management will host a conference call to discuss ...n of the website. About PharmAthene, Inc. pharmathene was formed to meet the critical needs of the Unite...

PharmAthene Announces New Date for First Quarter 2009 Conference Call and Webcast

...ge for its first quarter 2009 financial results. The Company's first quarter 2009 financial results will now be released on Friday, May 15, 2009. pharmathene management will be hosting a conference call to discuss its first quarter 2009 financial results. The call is scheduled to begin at 10:00 a.m. Easter...

PharmAthene to Host First Quarter 2009 Conference Call and Webcast on Thursday, May 14, 2009

...ogical and chemical threats, announced today that its financial results for the first quarter of 2009 will be released on Thursday, May 14, 2009. pharmathene management will be hosting a conference call to discuss its first quarter 2009 financial results. The call is scheduled to begin at 10:00 a.m. Easter...

PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research

.... Wright, President and Chief Executive Officer of pharmathene commented, "We are very pleased to have had the op... these data to attendees at this conference allows pharmathene to continue to increase awareness of the progress ... Conference Call and Webcast Information pharmathene management will host a conference call to provide ...
Other Tags
(Date:12/19/2014)... -- All children should have their eyesight checked between ... eye experts say. The new vision-screening guidelines for ... U.S. National Center for Children,s Vision Health. The ... screening for eye problems, particularly vision issues that ... and strabismus (a disorder of eye alignment). Early ...
(Date:12/19/2014)... News) -- The cost of cancer treatment can cause ... finds. Researchers examined data from 1,000 people in ... or lung cancer. Of those patients, almost 900 had ... 100 had advanced cancer. Nearly half of the ... bills, which was linked with a poorer health-related quality ...
(Date:12/19/2014)... Dennis Thompson HealthDay Reporter ... Ebola,s entrance into the United States -- along with ... outbreak -- have highlighted cracks in the nation,s public ... health policy report released Thursday. Half of U.S. ... to infectious disease outbreaks. That was the main conclusion ...
(Date:12/19/2014)... 19, 2014 Novellus Healthcare Communications, ... Pharmacy & Clinics™, an independent journal that provides ... and caring for patients inside the pharmacy and ... to provide optimal access to quality care, Inside ... for the team treating and coordinating patient care ...
(Date:12/19/2014)... December 19, 2014 From November 24, 2014, ... training for the year 2014 in its Goa retreat ... year. Through the Indian winters, from November to March, Siddhi ... beautiful beach of Arambol, Goa. The Goa training sessions will ... intakes of yoga teacher training, the 10th intake is also ...
Breaking Medicine News(10 mins):Health News:Preschoolers Need Eye Screening, Experts Say 2Health News:Cancer Treatment Costs Weigh Heavily on Patients, Study Finds 2Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 2Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 3Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 4Health News:The Transformation of Retail Pharmacies into a Healthcare Delivery Center 2Health News:The Transformation of Retail Pharmacies into a Healthcare Delivery Center 3Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 2Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 3
(Date:12/11/2014)... ST. PAUL, Minn. , Dec. 10, 2014 ... in wireless physiologic monitoring, has released a new ... changing needs of preclinical toxicology researchers. M series, ... to help toxicologists collect the best possible physiologic ... studies. Adding functional endpoints to toxicology ...
(Date:12/10/2014)... , Dec. 9, 2014  Valencell, a leader in ... seeing a staggering demand from its licensees for highly ... revealed, is not solely coming from fitness and health ... "A wearable is only as useful as ... is the ultimate driver in long-term mass consumer adoption ...
(Date:12/10/2014)... CIE San Diego has launched an innovative ... tissue that enhances care coordination among social service and ... information; earned a second $1 million grant from the ... aging in community and; will be recognized as a ... 4-6p. CIE San Diego today announced ...
Breaking Biology News(10 mins):New telemetry implants expected to change how large animal toxicology studies are conducted 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
Other Contents